AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SOUTH LAKE TAHOE, NEW. -- The use of harvested dendritic cells may be the key to producing a vaccine to treat cervical cancer, according to Dr. Ricardo Estape.
So far, research on the use of vaccines to treat cancer has run into serious and frustrating roadblocks, Dr. Estape said at an obstetrics and gynecology conference sponsored by the University of California, Davis.
But that has been because the peptides or viral particles used in the vaccines to provoke a response, when simply released into circulation, have not been taken up properly by antigen-presenting cells of the immune system. The result has been an induction of a B-cell-mediated humor response rather than a T-cell-mediated cellular response, which is the more important response for cancers and viral infection, said Dr. Estape of the department of gynecologic oncology at the University of Miami.
The ...
Source: HighBeam Research, Dendritic Cells Eyed for Cervical Cancer Vaccine.